These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 31567151)

  • 1. Dose-Dependent Escitalopram-Associated Ventricular Bigeminy.
    Naguy A; Al-Humoud AM; AlAwadhi DS; Khraibut B
    Am J Ther; 2020; 27(3):e307-e309. PubMed ID: 31567151
    [No Abstract]   [Full Text] [Related]  

  • 2. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
    Pallanti S; Quercioli L; Koran LM
    J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose escitalopram treatment in patients with obsessive-compulsive disorder: a naturalistic case series.
    Shim GS; Kang DH; Kwon JS
    J Clin Psychopharmacol; 2008 Feb; 28(1):108-10. PubMed ID: 18204356
    [No Abstract]   [Full Text] [Related]  

  • 4. Visual and auditory hallucinations associated with citalopram treatment.
    Waltereit R; Eifler S; Schirmbeck F; Zink M
    J Clin Psychopharmacol; 2013 Aug; 33(4):583-4. PubMed ID: 23775056
    [No Abstract]   [Full Text] [Related]  

  • 5. Supramaximal Dose of Ecitalopram-Associated Hematuria in an Adolescent With Obsessive-Compulsive Disorder: A Case Report.
    Naguy A; Abdelhamid HS; Elsori D; Alamiri B
    J Clin Psychopharmacol; 2020; 40(1):102-103. PubMed ID: 31834092
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe and moderate hypertriglyceridemia secondary to citalopram and fluoxetine.
    Teitelbaum M
    Psychosomatics; 2000; 41(5):448-9. PubMed ID: 11015636
    [No Abstract]   [Full Text] [Related]  

  • 7. Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.
    Sarkar R; Klein J; Krüger S
    Psychopharmacology (Berl); 2008 May; 197(4):687-8. PubMed ID: 18264798
    [No Abstract]   [Full Text] [Related]  

  • 8. Citalopram in refractory obsessive-compulsive disorder: an open study.
    Marazziti D; Dell'Osso L; Gemignani A; Ciapparelli A; Presta S; Nasso ED; Pfanner C; Cassano GB
    Int Clin Psychopharmacol; 2001 Jul; 16(4):215-9. PubMed ID: 11459335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison.
    Matreja PS; Badyal DK; Khosla P; Deswal RS
    Hum Psychopharmacol; 2007 Oct; 22(7):477-82. PubMed ID: 17647298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High doses of sertraline for treatment-resistant obsessive-compulsive disorder.
    Byerly MJ; Goodman WK; Christensen R
    Am J Psychiatry; 1996 Sep; 153(9):1232-3. PubMed ID: 8780435
    [No Abstract]   [Full Text] [Related]  

  • 11. Escitalopram in the treatment of obsessive-compulsive disorder.
    Zohar J
    Expert Rev Neurother; 2008 Mar; 8(3):339-49. PubMed ID: 18345966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to SSRI-induced enuresis: a case report.
    Ibrahim Ramadan M; Khan AY; Weston WE
    J Clin Psychopharmacol; 2006 Feb; 26(1):98-9. PubMed ID: 16415720
    [No Abstract]   [Full Text] [Related]  

  • 13. Yawning as a dose-dependent side effect of treatment with escitalopram.
    Roncero C; Mezzatesta-Gava M; Grau-López L; Daigre C
    Neurologia; 2013; 28(9):589-90. PubMed ID: 22795392
    [No Abstract]   [Full Text] [Related]  

  • 14. Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.
    Koponen H; Lepola U; Leinonen E; Jokinen R; Penttinen J; Turtonen J
    Acta Psychiatr Scand; 1997 Nov; 96(5):343-6. PubMed ID: 9395151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citalopram for treatment-resistant obsessive-compulsive disorder.
    Pallanti S; Quercioli L; Paiva RS; Koran LM
    Eur Psychiatry; 1999 Apr; 14(2):101-6. PubMed ID: 10572334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ziprasidone-associated mania in a case of obssessive-compulsive disorder.
    Wickham R; Varma A
    CNS Spectr; 2007 Aug; 12(8):578-9. PubMed ID: 17924512
    [No Abstract]   [Full Text] [Related]  

  • 17. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
    Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine augmentation of sertraline in obsessive-compulsive disorder.
    Francobandiera G
    J Clin Psychiatry; 2002 Nov; 63(11):1046-7. PubMed ID: 12469688
    [No Abstract]   [Full Text] [Related]  

  • 19. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.
    Ventura D; Armstrong EP; Skrepnek GH; Haim Erder M
    Curr Med Res Opin; 2007 Feb; 23(2):245-50. PubMed ID: 17288677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial.
    Ninan PT; Koran LM; Kiev A; Davidson JR; Rasmussen SA; Zajecka JM; Robinson DG; Crits-Christoph P; Mandel FS; Austin C
    J Clin Psychiatry; 2006 Jan; 67(1):15-22. PubMed ID: 16426083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.